spacer
home > pmps > summer 2002 > counterfeit drugs - a clear and present danger
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Counterfeit Drugs - A Clear and Present Danger

Drugs - An Easy Target

The tip of the iceberg is clearly visible and getting larger by the day. Drug counterfeiting and diversion are flourishing in today's world of tumbling international trade barriers, easy global marketing reach via the Internet, and simple access to sophisticated manufacturing and packaging technologies. Drug counterfeiting has steadily evolved from small-scale, opportunistic, activities in less regulated parts of the world to what has now become a widespread global threat to consumers and brand owners. Informed estimates put the size of the annual global market in fake drugs somewhere in the region of US$30 billion, representing about seven per cent of pharmaceutical industry revenue. Even more alarming are results of surveys showing that counterfeit drugs in some countries comprise in excess of 50 per cent of the market. These activities clearly put consumers at risk, threaten corporate and brand integrity, and generate significant cash for organised crime and terrorist groups.

Pharmaceuticals are an attractive target to counterfeiters, mainly because they have a high value in relation to their physical bulk. Consider some of the anti-cancer and anti-HIV treatments where a single pallet of product can represent many millions of dollars - for example, a standard 12-week course of Serostim treatment for HIV/AIDS patients costs approximately US$21,000.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr James Rittenburg, Vice President of Technology and Business Development at Biocode Dr James Rittenburg joined Biocode in 1994 and is currently Vice President of Technology and Business Development. He received his PhD in Microbiology from the University of Maine at Orono in 1981 and has over 20 years' experience developing immunodiagnostic systems for detecting trace levels of chemicals in samples including pharmaceuticals, foods, beverages, petrochemicals and agricultural products.
He has edited several books, authored numerous journal articles and is an inventor on a number of patents in this field. Prior to joining Biocode, James was Director of Product Development for Quantix Systems, where he had responsibility for overseeing the development of immunodiagnostic systems for detecting and measuring environmental pollutants.

spacer
Dr James Rittenburg
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge boom in Korean Pharma reported at CPhI Korea

Amsterdam, 19th September 2019: The recently-closed CPhI Korea – co-organised by Informa Markets and the Korea Pharmaceutical Traders Association (KPTA) – has seen a surge in growth across domestic and international pharma companies, as well as a sizable rise in overall attendees. As reported earlier this year in the provisional findings of the CPhI Pharma Index[1], Korea has seen a rapid growth in its international reputation (seeing its ‘overall competitiveness’ rise 14% in the last two years), which is now translating into a sizable growth in the market and at the event.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 
Industry Events

INTERPHEX 2020

15-17 July 2020, Javits Center NYC


More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement